RÉSUMÉ
BACKGROUND AND AIMS: Aerosols and droplets are the main vectors in transmission of highly contagious SARS-CoV-2. Invasive diagnostic procedures like upper airway and gastrointestinal endoscopy have been declared as aerosol-generating procedures. Protection of healthcare workers is crucial in times of the COVID-19 pandemic. METHODS: We simulated aerosol and droplet spread during upper airway and gastrointestinal endoscopy with and without physico-mechanical barriers using a simulation model. RESULTS: A clear plastic drape as used for central venous access markedly reduced visualized aerosol and droplet spread during endoscopy. CONCLUSION: A simple and cheap drape has the potential to reduce aerosol and droplet spread during endoscopy. In terms of healthcare worker protection, this may be important particularly in low- or moderate-income countries.
Sujet(s)
COVID-19 , Humains , SARS-CoV-2 , Pandémies/prévention et contrôle , Transmission de maladie infectieuse du patient au professionnel de santé/prévention et contrôle , Gouttelettes et aérosols respiratoires , Endoscopie , Endoscopie gastrointestinaleRÉSUMÉ
BACKGROUND: In Germany, following the principle "sickest first", patients awaiting liver transplantation (LTPL) are often transplanted with high MELD score and run the risk that they can no longer be transplanted, getting "too sick for transplant". METHODS: In a retrospective single-center study, we analyzed the mortality of adult patients on the waiting list for LTPL during the years 2014 to 2017. To stratify risk factors, we compared characteristics of deceased and transplanted patients. RESULTS: The main reasons for mortality were sepsis (42.9â%), malignancy (24.3â%) and bleeding (10.0â%). Risk factors for mortality (OR, univariate logistic regression, pâ<â0.05) were acute on chronic liver failure (ACLF), loss of E-MELD, sepsis, pneumonia, proof of pathogens, candidemia, stay at ICU, multiple organ failure and mechanical ventilation. Multivariate analysis revealed pneumonia (pâ<â0.001) and high MELD (pâ=â0.031) as risk factors. Transplantation was more likely in patients with E-MELD. We suggest a Waiting List Mortality Index for Transplantation (WMIT), by dividing deceased patients to transplanted patients to assess mortality. Average WMIT in our cohort was 0.65. CONCLUSIONS: Mortality on the waiting list is mainly determined by pneumonia and infections in high-MELD patients. Therefore, patients with ACLF after infections should be prioritized for LTPL. A WMIT might suitably represent waiting list mortality.
Sujet(s)
Maladie du foie en phase terminale/mortalité , Maladie du foie en phase terminale/chirurgie , Transplantation hépatique/statistiques et données numériques , Listes d'attente/mortalité , Maladie du foie en phase terminale/complications , Allemagne/épidémiologie , Humains , Sélection de patients , Études rétrospectives , Facteurs de risque , Indice de gravité de la maladie , Acquisition d'organes et de tissus/méthodes , Résultat thérapeutiqueRÉSUMÉ
Purpose Evaluation of clinical impact regarding diagnostic and therapeutic changes influenced by interdisciplinary radiological case presentations. Materials and Methods Prospective evaluation of radiological-gastrointestinal clinical case conferences over a 1-year period at a tertiary care center. We documented the preparation (phase 1) and clinical case conference (phase 2) regarding their impact on the radiology report and further diagnostic work-up and therapy. Results 1067 examinations were evaluated in 69 clinical case conferences including 487 cases. We calculated a mean time of 35.8 minutes per conference with 5.1 minutes per case for preparation. During phase 1, major changes compared to the previous report were found in 1.2â% of cases, and no change was found in 91.4â% of cases. In phase 2 an additional relevant finding was found in 0.6â% of cases, while there was no major change to the reports in 99â% of cases. We recommended further radiological diagnostic workup in 9â% of cases and interventional radiological examination in 2.7â% of cases, while no change was documented in 83.2â%. Further radiological or surgical therapy was recommended in 7â% and 6.8â% of cases, respectively. There was no change in therapy in 78.5â% of cases. Conclusion The analysis of an interdisciplinary radiological case presentation in internal medicine shows that the case discussion with the radiologist results in a change in patient management in 37.3â% of cases (16.8â% diagnosis, 21.5â% therapy). Overall, interdisciplinary radiological clinical case conferences help to improve the management and quality of patient care. Our data support the broad implementation of radiological clinical case conferences. Key Points · The second opinion obtained during the preparation of a radiological case presentation does not change the written report in most cases.. · "Talking radiology" in radiological case presentations results in a significant change in patient management in over â of all cases.. · In radiological clinical case conferences an experienced radiologist can initiate diagnostic and interventional radiological methods that can be correctly implemented in therapeutic pathways.. · "Talking radiology" improves the quality of therapy and patient care.. Citation Format · Dendl L. M., Teufel A., Schleder S. etâal. Analysis of Radiological Case Presentations and their Impact on Therapy and Treatment Concepts in Internal Medicine. Fortschr Röntgenstr 2017; 189: 239â-â246.
Sujet(s)
Programme clinique/normes , Imagerie diagnostique/normes , Maladies gastro-intestinales/imagerie diagnostique , Maladies gastro-intestinales/thérapie , Communication interdisciplinaire , Médecine interne/normes , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Prise de décision clinique , Imagerie diagnostique/statistiques et données numériques , Femelle , Maladies gastro-intestinales/épidémiologie , Allemagne/épidémiologie , Humains , Mâle , Adulte d'âge moyen , Prévalence , Indicateurs qualité santé/normes , Appréciation des risques , Résultat thérapeutique , Jeune adulteRÉSUMÉ
PURPOSE: To compare outcomes of transarterial chemoembolization with degradable starch microspheres (DSMs) and conventional transarterial chemoembolization with doxorubicin and Ethiodol in patients with unresectable intermediate-stage hepatocellular carcinoma (HCC). MATERIALS AND METHODS: A total of 69 patients underwent 169 chemoembolization procedures with Ethiodol (n = 35) or DSMs (n = 34) as the embolic agent. The same chemotherapeutic agent was used for all patients (50 mg doxorubicin). The primary endpoint was patient survival, and secondary endpoints were local tumor response and incidence of therapy-associated complications with conventional or DSM chemoembolization. Tumor response was evaluated by consensus reading by two radiologists in accordance with modified Response Evaluation Criteria In Solid Tumors. Mean survival was calculated according to Kaplan-Meier analysis, and differences in survival curves were assessed by univariate log-rank test. The statistical significance of quantitative variables was determined by parameter-free Wilcoxon-Mann-Whitney U test. RESULTS: The study groups were similar with regard to demographic data and disease stage. For the DSM chemoembolization group, the objective response rate (ie, complete or partial response) was 44.1%, and the rate of stable disease was 38.2%. The respective rates for the conventional chemoembolization group were 48.6% and 31.4%. Mean survival (P = .337) and complications did not significantly differ between groups (P = .907; P = 1.000). CONCLUSIONS: DSM chemoembolization represents an alternative method of HCC treatment with a safety profile similar to that of conventional transarterial chemoembolization. Regarding local tumor response and overall survival, results of DSM chemoembolization were similar to those of conventional chemoembolization.
Sujet(s)
Antibiotiques antinéoplasiques/administration et posologie , Carcinome hépatocellulaire/thérapie , Chimioembolisation thérapeutique/méthodes , Doxorubicine/administration et posologie , Huile éthiodée/administration et posologie , Tumeurs du foie/thérapie , Amidon/administration et posologie , Sujet âgé , Antibiotiques antinéoplasiques/effets indésirables , Carcinome hépatocellulaire/vascularisation , Carcinome hépatocellulaire/mortalité , Carcinome hépatocellulaire/anatomopathologie , Chimioembolisation thérapeutique/effets indésirables , Chimioembolisation thérapeutique/mortalité , Doxorubicine/effets indésirables , Huile éthiodée/effets indésirables , Femelle , Humains , Estimation de Kaplan-Meier , Tumeurs du foie/vascularisation , Tumeurs du foie/mortalité , Tumeurs du foie/anatomopathologie , Mâle , Adulte d'âge moyen , Stadification tumorale , Études rétrospectives , Amidon/effets indésirables , Facteurs temps , Tomodensitométrie , Résultat thérapeutiqueRÉSUMÉ
OBJECTIVE: Nitric oxide (NO), catalyzed by inducible NO synthase (iNOS), may be important in the pathophysiologic characteristics of many vascular diseases. Although there is indirect evidence to support the presence of iNOS in abdominal aortic aneurysm (AAA) in human beings, no definitive study has confirm this finding. The present study was designed to assess expression of iNOS in AAA in human beings. Furthermore, the activity of iNOS and the oxidative vascular injury initiated by iNOS were assessed with detection of nitrotyrosine, which is a marker indicative of formation and activity of the NO-derived oxidant peroxynitrite. METHODS: We studied 25 patients with AAA and 10 patients with normal abdominal aortas. In situ hybridization and immunohistochemistry were used in tissue sections to localize iNOS messenger RNA (mRNA) and protein. Double staining with a combination of in situ hybridization and immunohistochemistry was used to simultaneously demonstrate iNOS mRNA expression and its cellular localization. The presence of peroxynitrite was indirectly assessed with immunostaining with anti-nitrotyrosine antibodies. RESULTS: In situ hybridization and immunohistochemistry confirmed the presence of iNOS in media and adventitia of AAA in all 25 patients. Specific cell markers identified iNOS mRNA-positive cells mainly as T and B lymphocytes, macrophages, and smooth muscle cells. Positive immunostaining for nitrotyrosine was present in macrophages and smooth muscle cells. Normal abdominal aorta demonstrated virtually no iNOS or nitrotyrosine expression. CONCLUSION: Stimulated expression of iNOS is associated with degeneration of AAA in human beings, and the activity of this enzyme under such conditions preferentially promotes formation and activity of peroxynitrite and further contributes to oxidative tissue and cellular injury in AAA. This may be important in the pathogenesis of AAA.